daunorubicin has been researched along with 9,10-dimethyl-1,2-benzanthracene in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Philips, FS; Sternberg, SS | 1 |
| Perchellet, JP; Satyamoorthy, K | 1 |
| Gasiorowski, K; Szyba, K; Urban, J | 1 |
3 other study(ies) available for daunorubicin and 9,10-dimethyl-1,2-benzanthracene
| Article | Year |
|---|---|
Tests for tumor induction by antitumor agents.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Benz(a)Anthracenes; Carcinogens; Dactinomycin; Daunorubicin; DNA; Female; Hydroxyurea; Mammary Neoplasms, Experimental; Mice; Mice, Inbred A; Neoplasms, Experimental; Rats | 1975 |
Modulation by adriamycin, daunomycin, verapamil, and trifluoperazine of the biochemical processes linked to mouse skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Administration, Topical; Animals; Daunorubicin; DNA; Doxorubicin; Female; Mice; Neoplasms, Experimental; Ornithine Decarboxylase; RNA; Skin Neoplasms; Tetradecanoylphorbol Acetate; Time Factors; Trifluoperazine; Verapamil | 1989 |
Todralazine influence upon the mutagenicity of some direct- and indirect-acting mutagens.
Topics: 4-Nitroquinoline-1-oxide; 9,10-Dimethyl-1,2-benzanthracene; Aminacrine; Antimutagenic Agents; Azides; Benzo(a)pyrene; Biotransformation; Daunorubicin; Dose-Response Relationship, Drug; Methyl Methanesulfonate; Methylcholanthrene; Microsomes, Liver; Mitomycin; Mutagenicity Tests; Mutagens; Salmonella typhimurium; Sodium Azide; Todralazine | 1994 |